A new publication dated July 1, 2026 discusses the peptide KPV within a broader review of peptide and peptide-analog drugs used in recreational and professional sport and bodybuilding. The article, titled "A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review," appeared in The Journal of Sports Medicine and Physical Fitness.
The publication is identified as a critical review examining the landscape of peptide drug use in athletic and bodybuilding contexts. KPV is named among the peptide compounds covered in this review.
KPV remains classified as an unapproved research compound. No dosing information, clinical outcomes, or efficacy data from this review have been detailed here beyond confirming its publication and subject matter.
This brief reports only that the review was published and that it addresses peptide and peptide-analog drug use in sport, including reference to KPV. No findings, conclusions, or safety determinations from the review are summarized in this notice.
Readers interested in additional background on KPV can consult the compound overview for further context.